It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LONA’s FA Score shows that 1 FA rating(s) are green whileSLBT’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LONA’s TA Score shows that 5 TA indicator(s) are bullish while SLBT’s TA Score has 5 bullish TA indicator(s).
LONA (@Biotechnology) experienced а +4.30% price change this week, while SLBT (@Biotechnology) price change was +0.22% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.36%. For the same industry, the average monthly price growth was +13.64%, and the average quarterly price growth was +1748.63%.
LONA is expected to report earnings on Aug 17, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| LONA | SLBT | LONA / SLBT | |
| Capitalization | 82.1M | 2.45B | 3% |
| EBITDA | -41.83M | N/A | - |
| Gain YTD | 15.456 | -57.705 | -27% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 0 | N/A | - |
| Total Cash | 67.7M | N/A | - |
| Total Debt | 691K | N/A | - |
| LONA | SLBT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 56% |
| Momentum ODDS (%) | 1 day ago 84% | 1 day ago 58% |
| MACD ODDS (%) | 1 day ago 82% | 1 day ago 32% |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 62% |
| TrendMonth ODDS (%) | 1 day ago 81% | 1 day ago 88% |
| Advances ODDS (%) | 14 days ago 83% | N/A |
| Declines ODDS (%) | 30 days ago 85% | 16 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 60% |
| Aroon ODDS (%) | 1 day ago 80% | N/A |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CEFA | 39.16 | N/A | N/A |
| Global X S&P Cthlc Vls Dvlpd ex-US ETF | |||
| NPCT | 9.97 | N/A | N/A |
| Nuveen Core Plus Impact Fund | |||
| TIPX | 18.75 | -0.01 | -0.05% |
| State Street® SPDR® Blmbg 1-10 YrTIPSETF | |||
| DUKZ | 25.37 | -0.04 | -0.16% |
| Ocean Park Diversified Income ETF | |||
| RMCA | 24.38 | -0.07 | -0.27% |
| Rockefeller California Municipal Bd ETF | |||
A.I.dvisor indicates that over the last year, LONA has been closely correlated with APVO. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if LONA jumps, then APVO could also see price increases.
| Ticker / NAME | Correlation To LONA | 1D Price Change % | ||
|---|---|---|---|---|
| LONA | 100% | N/A | ||
| APVO - LONA | 82% Closely correlated | N/A | ||
| CANF - LONA | 78% Closely correlated | -6.61% | ||
| GNPX - LONA | 76% Closely correlated | N/A | ||
| ICU - LONA | 75% Closely correlated | N/A | ||
| MLEC - LONA | 73% Closely correlated | N/A | ||
More | ||||
A.I.dvisor indicates that over the last year, SLBT has been loosely correlated with NMRA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SLBT jumps, then NMRA could also see price increases.
| Ticker / NAME | Correlation To SLBT | 1D Price Change % | ||
|---|---|---|---|---|
| SLBT | 100% | N/A | ||
| NMRA - SLBT | 44% Loosely correlated | N/A | ||
| HIND - SLBT | 3% Poorly correlated | N/A | ||
| NGEN - SLBT | -1% Poorly correlated | N/A | ||
| LONA - SLBT | -1% Poorly correlated | N/A | ||
| MSLE - SLBT | -1% Poorly correlated | N/A | ||
More | ||||